CymaBay Therapeutics Balance Sheet Health
Financial Health criteria checks 4/6
CymaBay Therapeutics has a total shareholder equity of $292.3M and total debt of $109.2M, which brings its debt-to-equity ratio to 37.4%. Its total assets and total liabilities are $434.7M and $142.4M respectively.
Key information
37.4%
Debt to equity ratio
US$109.17m
Debt
| Interest coverage ratio | n/a |
| Cash | US$394.26m |
| Equity | US$292.26m |
| Total liabilities | US$142.43m |
| Total assets | US$434.69m |
Recent financial health updates
CymaBay Therapeutics (NASDAQ:CBAY) Has Debt But No Earnings; Should You Worry?
Dec 28
Is CymaBay Therapeutics (NASDAQ:CBAY) Weighed On By Its Debt Load?
Jul 13Is CymaBay Therapeutics (NASDAQ:CBAY) Using Debt In A Risky Way?
Mar 17Is CymaBay Therapeutics (NASDAQ:CBAY) Weighed On By Its Debt Load?
Dec 03We Think CymaBay Therapeutics (NASDAQ:CBAY) Can Afford To Drive Business Growth
May 15Recent updates
CymaBay Therapeutics, Inc. (NASDAQ:CBAY) Analysts Just Slashed Next Year's Revenue Estimates By 17%
Feb 15Analysts' Revenue Estimates For CymaBay Therapeutics, Inc. (NASDAQ:CBAY) Are Surging Higher
Dec 22CymaBay Therapeutics (NASDAQ:CBAY) Has Debt But No Earnings; Should You Worry?
Dec 28CymaBay Therapeutics GAAP EPS of -$0.31 misses by $0.01
Aug 11Is CymaBay Therapeutics (NASDAQ:CBAY) Weighed On By Its Debt Load?
Jul 13CymaBay: Long-Term Potential Based On Prior PBC Trial Results
Jun 27Is CymaBay Therapeutics (NASDAQ:CBAY) Using Debt In A Risky Way?
Mar 17Why I've Taken A 'Starter' Position In CymaBay Therapeutics
Jan 20Is CymaBay Therapeutics (NASDAQ:CBAY) Weighed On By Its Debt Load?
Dec 03We Think CymaBay Therapeutics (NASDAQ:CBAY) Can Afford To Drive Business Growth
May 15We're Hopeful That CymaBay Therapeutics (NASDAQ:CBAY) Will Use Its Cash Wisely
Jan 29
CymaBay Therapeutics (CBAY) Presents At AASLD 2020 Conference- Slideshow
Nov 17CymaBay Is Clawing Back, Now We Just Need Pipeline Conversion
Nov 08CymaBay Therapeutics EPS in-line
Nov 05Financial Position Analysis
Short Term Liabilities: CBAY's short term assets ($403.8M) exceed its short term liabilities ($36.8M).
Long Term Liabilities: CBAY's short term assets ($403.8M) exceed its long term liabilities ($105.6M).
Debt to Equity History and Analysis
Debt Level: CBAY has more cash than its total debt.
Reducing Debt: CBAY's debt to equity ratio has increased from 0% to 37.4% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: CBAY has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if CBAY has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.